Skip to main content
. 2016 May 23;7(26):40189–40199. doi: 10.18632/oncotarget.9561

Figure 4. Diagnostic outcomes for fibrinectin (FN) in the diagnosis of breast cancer (BC) using ELISA method 1 and 2.

Figure 4

A. ROC curves for FN for all patients with BC versus three control groups in test set. B. ROC curves for FN for all patients with BC versus three control groups in validation set.